In addition, the presence of anti-ADAMTS13 antibodies during pregnancy was associated with an over 6.6-fold increased risk for gravidic TTP and with an over 4.1-fold increased risk for miscarriage. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.